focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Money- it’s about time to on all fronts. Huge appetite for bio companies just now.
GLA
Harley there is a group, if you go on twitter and type #genf you’ll be able to find it, as it won’t show the pathway here if I type it.
Cheers Porter, and full market interest can't be far off Northeast, and I'm sure Eric is ready to deliver a flow of positive news....the Biotech sector at long last could be ready for some serious UPside and market appreciation, judging by today's Top risers board and Genflow's tiny market offers tremendous UPside potential. Gl :-)
Is there a group??
Fantastic read. One day the market will get what we are all about
GLA
Lovely find Munch. May explain the sudden jump in share price.
Great to see the company being recognised as one to be watched for the life changing science it can offer!
The Gaurdian....Company to Watch 2024!!!
4th January 2024
Genflow Biosciences
Longevity is not just for billionaires, says Dr Eric Leire, the founder and chief executive of Genflow Biosciences, which in December 2022 became the first anti-ageing biotech to list in Europe.
The London-listed and headquartered company, which has its labs in Belgium and an office in Cambridge, Massachusetts, is developing gene therapies for longer, healthier lives.
The company’s work is based on a rare mutation of the SIRT6 gene found in people who live beyond the age of 100, which was discovered by Dr Vera Gorbunova’s team at the University of Rochester in 2019. She chairs Genflow’s scientific advisory board.
“Some people are lucky to have the good gene, and what we want to do is share that luck with everybody,” says Leire, who previously worked for Pfizer and Schering-Plough.
Genflow plans to test an experimental therapy on people with an age-related liver disease called NASH in early 2025. It is also developing a therapy for Werner syndrome, a rare accelerated ageing disease, by which SIRT6 messenger RNA delivers the gene to the skin. Genflow is also launching a programme to prevent age-related loss of muscle mass, funded by new research grants.
It started trading on the OTCQB venture market in the US in the summer, to expand its reach to US investors. As an early-stage biotech, Genflow is a risky investment; its London-listed shares have lost nearly 90% of their value in the first year of trading. But it is certainly one to watch. The longevity science sector is forecast to reach $2bn (£1.6bn) by 2030, according to Insight Analytics. Julia Kollewe
Much more to come Porter...A very Bright and Happy New Year!!! :-)
0 0 0
GenFlow Biosciences
1,380 followers
3m
GenFlow Biosciences (LSE: GENF) (OTCQB: GENFF) is thrilled to be named "a firm to watch" by the The Guardian today.
As clinical trials for patients suffering from NASH get underway in 2025, we are very excited for 2024 and beyond.
Read the article here: hTtps://loom.ly/PWx_em8 #GENF #longevity #healthspan #SIRT6 #smallcaps #companytowatch
Lovely start to the year Munch.
Also seeing some decent articles popping up on Longevity, with Phil Newman noting family offices have a particular interest in the sector.
The below article released yesterday also notes:
"In the third quarter of 2023, the US contributed to 65% of all deals in the longevity sector, a report revealed, but Europe is getting involved as well. France and Switzerland made up 23% of total deals, with the UK at 5%."
https://sifted.eu/articles/new-year-longer-life-what-longevity-has-to-offer-in-2024
I'm certainly glad to be invested before the ship departs :)
Get UP there!!! " A Bright New Year " ahead, with any Luck. In Eric we trust!!! ;-)
On and UP....it's been a while, hopefully in anticipation of a flow of imminent good news along with a significant re-rate or two....C'mon Eric....Gla holders..:-)
By rights, this should be at float or above.
It does seem like the CEO of GENFLOW does not seem to care about his shareholders, shame really as the science seems to be the future.
But
Why is the share price sitting just over a penny - it just does not make sense
He needs to be replaced by someone who has investors interests at heart and someone seasoned who can promote the science and the company to institutional investors.
Eric Leire seems to have gone to sleep- wakey wakey Eric where is the news and updates ?
If this was a horse it would be put out to graze
Yep, the slide in sp isn't great and has been very disappointing and so can't imagine Genflow posting such a message if they weren't going to back it up and expecting some good cheer....Gl :-)
I hope it’s a bright new year. Can’t get much worse than this.
GLA
A Christmas message just posted on Linkden!!! A very encouraging sign of good things to come me thinks??? Gla :-)))
"Wishing you Happy Holidays and a Bright New Year from the whole team at Genflow Biosciences."
hTtps://www.linkedin.com/posts/genflow-biosciences_activity-7143283719187963904-0T1s?utm_source=share&utm_medium=member_android
Cheers Northeast, hopefully everything is set for a stellar year ahead, and just need some good news from Eric to get the ball rolling and the sp heading North. Gl :-)
Evening Money,
Fantastic post! Hopefully the paper hands are out soon. Looking forward to a blockbuster 2024 here.
GLA
Science 20 DEC 2023
Sirtuin 6 Activation Reverses Age-Related DNA Repair Decline
"In conclusion, the findings presented here support the hypothesis that the efficiency of DNA damage repair declines with age in chondrocytes and that SIRT6 activation improves repair both in response to an acute irradiation challenge and in the context of age-related damage accumulation. These results emphasize the critical role of SIRT6 in DNA repair and support further studies investigating the use of MDL-800 (or alternative SIRT6 activators) in mitigating senescence induction and ameliorating OA development."
hTtps://www.miragenews.com/sirtuin-6-activation-reverses-age-related-dna-1147181/
Seems the seller is still about... this is so frustrating!... desperate for an update here.
Don't think this plant is ever going to bare fruit
Yep, we just need Eric to sprinkle a bit of joy....Final invivo results, grants/funding, a Major investor and or JV partner , C'mon Eric, when you’re ready!!! :-)))
Let the paper hands leave. Nothing has changed here.
GLA
Hoping this large sell is the last... let see..